Related Experiment Video
Updated: Jan 16, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Kyoto Classification-Based Predictive Factors Associated with the Development of Gastric Cancer After Helicobacter
Shun Takayama1, Osamu Dohi1, Ryusuke Horie2
1Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan.
Map-like redness and invisible regular arrangement of collecting venules (RAC) are key endoscopic findings predicting gastric cancer (GC) after H. pylori eradication. These indicators appear within one year, highlighting the need for early surveillance.
Area of Science:
- Gastroenterology
- Oncology
- Endoscopy
Background:
- Gastric cancer (GC) remains a significant health concern globally.
- Helicobacter pylori (H. pylori) infection is a primary risk factor for GC.
- Successful H. pylori eradication is crucial but does not eliminate GC risk entirely.
Purpose of the Study:
- To identify specific endoscopic findings predicting GC development post-H. pylori eradication.
- To analyze the association between endoscopic features and GC incidence using the Kyoto Classification of Gastritis.
- To establish early predictive indicators for GC in patients after H. pylori eradication.
Main Methods:
- Prospective multicenter observational study.
- Inclusion of patients undergoing annual surveillance endoscopy post-H. pylori eradication (Sept 2013 - June 2019).
- Analysis of endoscopic findings using the Kyoto Classification of Gastritis.
Main Results:
- 465 patients included; 49 developed GC.
- Map-like redness (HR 2.561) and invisible RAC (HR 3.131) identified as independent GC predictors.
- Significantly higher GC incidence in patients with map-like redness or invisible RAC (p < 0.001).
- Map-like redness and visible RAC observed in 13% and 28.4% within one year post-eradication.
Conclusions:
- Map-like redness and invisible RAC are significant independent predictors of GC after H. pylori eradication.
- These endoscopic findings serve as early indicators of elevated GC risk.
- Early surveillance endoscopy is vital for identifying high-risk patients post-eradication.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

